This offering represents the opportunity to acquire a licensed and accredited outpatient behavioral health provider operating in a highly supply-constrained Maryland market. The company delivers structured addiction treatment services through established outpatient programming and has developed a strong reputation among referral partners, payers, staff, and the local community.

The business is licensed by the Maryland Behavioral Health Administration and holds CARF accreditation, creating meaningful regulatory and operational barriers to entry. Maryland has paused issuing new outpatient behavioral health licenses across many major counties, materially increasing the scarcity value of existing licensed operators. As a result, established providers with compliant operations and accreditation are increasingly sought after by strategic buyers and private equity-backed platforms seeking regulated market access.

Services include outpatient levels of care designed to support patients across varying clinical needs. Operations are supported by credentialed clinical leadership, licensed therapists, case management, and administrative staff. Intake, billing, compliance, and clinical documentation systems are in place, allowing the platform to operate efficiently and scale under experienced ownership.

The business benefits from consistent referral demand and a stable payer environment. Revenue is predominantly supported by Medicaid reimbursement, which provides predictability and limits exposure to commercial payer volatility. Seasonal fluctuations are typical, with demand remaining strong during peak periods and occasional staffing constraints creating waitlists.

Financial performance reflects the company’s growth phase and periods of reinvestment. After early-stage operating losses driven by startup costs, staffing investments, and infrastructure buildout, the business reached profitability and continues to demonstrate improving operational leverage. While recent reported results reflect transitional expenses and normalization efforts, the company exhibits a normalized EBITDA profile when adjusting for owner compensation, discretionary expenses, and non-recurring items.

An independent valuation prepared for institutional and private equity buyers supports a Fair Market Value range of approximately $1.4M to $1.8M. The valuation is supported by adjusted EBITDA analysis, revenue cross-checks, comparable market transactions, accreditation status, payer stability, and the scarcity of licensed outpatient operators in Maryland. A detailed EBITDA bridge, valuation report, and supporting financial documentation will be made available to qualified buyers upon execution of a Non-Disclosure Agreement.

The platform presents multiple avenues for value creation under new ownership. Opportunities include staffing optimization, increased patient capacity, enhanced referral and marketing execution, improved utilization of existing licenses, and operational efficiencies. Additional upside may exist through expansion into higher-acuity services, including residential treatment, subject to regulatory approvals, or through geographic expansion within license-restricted regions.

This opportunity is well suited for strategic healthcare operators, private equity-backed behavioral health platforms, or experienced owner-operators seeking a scalable, regulated asset with predictable payer support. Due to the sensitive nature of healthcare operations, staff, and patient relationships, confidentiality is required. Business name, location, and identifying details will be disclosed only to financially qualified buyers who execute an NDA and demonstrate acquisition capability.